BindingDB logo
myBDB logout

BDBM325048 2-(4-(4-((2-(2-isopropylphenyl)-8-oxo-7,8-dihydro-9H-::US10189841, Compound I-254::US10399980, Compound I-254

SMILES: CC(C)c1ccccc1-c1ncc2[nH]c(=O)n(Cc3ccc(cc3)-c3cnn(C)c3CC(O)=O)c2n1

InChI Key: InChIKey=LUCFOBLOYFGXOD-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 325048   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Ubiquitin carboxyl-terminal hydrolase 1


(Homo sapiens (Human))
BDBM325048
PNG
(2-(4-(4-((2-(2-isopropylphenyl)-8-oxo-7,8-dihydro-...)
Show SMILES CC(C)c1ccccc1-c1ncc2[nH]c(=O)n(Cc3ccc(cc3)-c3cnn(C)c3CC(O)=O)c2n1
Show InChI InChI=1S/C27H26N6O3/c1-16(2)19-6-4-5-7-20(19)25-28-14-22-26(31-25)33(27(36)30-22)15-17-8-10-18(11-9-17)21-13-29-32(3)23(21)12-24(34)35/h4-11,13-14,16H,12,15H2,1-3H3,(H,30,36)(H,34,35)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a>2.00E+3n/an/an/an/an/an/a



FORMA Therapeutics, Inc.

US Patent


Assay Description
The HTS assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning...


US Patent US10399980 (2019)


BindingDB Entry DOI: 10.7270/Q23J3GCX
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 1


(Homo sapiens (Human))
BDBM325048
PNG
(2-(4-(4-((2-(2-isopropylphenyl)-8-oxo-7,8-dihydro-...)
Show SMILES CC(C)c1ccccc1-c1ncc2[nH]c(=O)n(Cc3ccc(cc3)-c3cnn(C)c3CC(O)=O)c2n1
Show InChI InChI=1S/C27H26N6O3/c1-16(2)19-6-4-5-7-20(19)25-28-14-22-26(31-25)33(27(36)30-22)15-17-8-10-18(11-9-17)21-13-29-32(3)23(21)12-24(34)35/h4-11,13-14,16H,12,15H2,1-3H3,(H,30,36)(H,34,35)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a<0.00200n/an/an/an/an/an/a



FORMA Therapeutics, Inc.

US Patent


Assay Description
The HTS assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning...


US Patent US10189841 (2019)


BindingDB Entry DOI: 10.7270/Q22R3TRR
More data for this
Ligand-Target Pair